Filter
3053
Filtered Results: 3053
Text search:
pharmacies
Featured
Recommendations
266
New Publications
813
Language
Document type
No document type
1512
Studies & Reports
577
Guidelines
495
Manuals
134
Strategic & Response Plan
122
Fact sheets
83
Training Material
38
Situation Updates
29
Resource Platforms
24
Brochures
14
Infographics
14
Online Courses
8
Videos
2
App
1
Countries / Regions
Kenya
123
Global
112
Ethiopia
93
India
92
Congo, Democratic Republic of
65
South Africa
65
Senegal
59
Nigeria
56
Western and Central Europe
54
Sierra Leone
53
Liberia
53
Rwanda
52
Uganda
51
Nepal
46
Benin
45
Burkina Faso
45
Tanzania
43
Ukraine
41
Ghana
40
Africa
40
Bangladesh
39
Malawi
37
Latin America and the Carribbean
36
Zambia
35
Haiti
34
Cameroon
32
Namibia
32
Syria
24
West and Central Africa
24
Germany
22
Eastern Europe
22
Myanmar / Burma
22
Philippines
21
Cambodia
21
South–East Asia Region
21
Indonesia
21
Zimbabwe
20
Madagascar
20
Guinea
19
Lesotho
16
East and Southern Africa
16
Russia
16
Venezuela
15
Central African Republic
15
Botswana
14
Mali
13
Eswatini/ Swaziland
13
Asia
12
Eastern Europe and Central Asia
12
South Sudan
11
Brazil
10
Mozambique
9
Middle East and North Africa
9
Pakistan
8
Thailand
7
Chile
7
Albania
7
Sudan
7
Niger
6
Côte d’Ivoire / Ivory Coast
6
Tajikistan
5
Togo
5
Laos
5
Afghanistan
5
Vietnam
5
Papua New Guinea
5
Chad
5
China
4
Canada
4
Western Pacific Region
4
North America
4
France
4
Moldova
4
North Macedonia
3
Kazakhstan
3
Fiji
3
Kyrgyzstan
3
Peru
3
USA
3
Jordan
3
United Kingdom
3
Lebanon
3
Sri Lanka
3
Egypt
3
Georgia
3
Iraq
3
Colombia
2
Serbia
2
Burundi
2
Morocco
2
Lithuania
2
Paraguay
2
Gabon
2
Turkmenistan
2
Jamaica
2
Spain
2
Southern Africa
2
Bolivia
2
Argentina
2
Angola
2
Libya
2
Bhutan
2
Somalia
2
Switzerland
1
Timor Leste/ East Timor
1
El Salvador
1
Turkey
1
Australia
1
Iran
1
Estonia
1
Congo-Brazzaville
1
Uzbekistan
1
Malaysia
1
Mongolia
1
Qatar
1
Bulgaria
1
Armenia
1
Guinea-Bissau
1
Ireland
1
Saudi Arabia
1
Luxembourg
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Portugal
1
Latvia
1
Djibouti
1
Yemen
1
Romania
1
Palestine
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
1375
Clinical Guidelines
180
Public Health
131
Key Resources
88
Women & Child Health
81
Pharmacy & Technologies
60
Capacity Building
34
Annual Report MEDBOX
2
Toolboxes
COVID-19
305
AMR
254
Pharmacy
248
HIV
189
TB
154
Mental Health
149
Ebola
71
Rapid Response
65
Caregiver
63
Conflict
61
NCDs
58
Planetary Health
57
NTDs
56
Refugee
44
Global Health Education
41
Health Financing Toolbox
26
Disability
17
Natural Hazards
12
Specific Hazards
10
Cholera
8
Polio
8
Social Ethics
4
Zika
4
Health Financing
2
The world has been turned on its head by the coronavirus disease 2019 (COVID-19) pandemic. This has provided a stark wakeup call on the severe under-financing of health systems around the world. It has laid bare the inequalities and limitations in the capacities of countries at all levels of develop...
Since the 1970s, voluntary contributions have become an increasingly important component of WHO's budget. As voluntary contributions tend to be earmarked for donor-specified programmes and projects, there are concerns that this trend has diverted focus away from WHO's strategic priorities, made coor...
The increasing amounts of official development assistance (ODA) for health have been aimed primarily at fighting HIV/AIDS, malaria and tuberculosis. Neglected tropical diseases (NTD), one of the most serious public health burdens among the most deprived communities, have only recently drawn the atte...
This report analyses the intersection of HIV, COVID-19 and public debt in developing countries. The collision between COVID-19 and a crippling debt crisis have reversed decades of progress - putting present and future investments in health and HIV at risk. Pragmatic options to address the pandemic t...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...
The thirty-seventh meeting of the Programme, Budget and Administration Committee was held in Geneva from 25 to 27 January 2023 and chaired by Ms Aishath Rishmee (Maldives). The Committee adopted its agenda and agreed its programme of work. In his opening remarks, the Director-General emphasized the ...
This report examines the support to private healthcare provision in India by the World Bank’s private sector arm, the International Finance Corporation (IFC). Despite supporting private healthcare in the country since 1997, no healthcare results for lending and investments have been disclosed sinc...
This resource pack was developed for the country offices of the World Health Organization and national Public Health institutions, as an overview of the key information needed for advising their Member States in response to questions raised on human health due to influenza outbreaks or detections in...
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome ...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
This article analyzes the impact of the COVID-19 pandemic on foreign aid. Using examples from Canadian foreign aid, it argues that, despite the terrible toll it is exacting, the crisis has accelerated some significant positive pre-existing trends, both by destabilizing the perception of aid as flowi...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
